FDA 510(k) rejections for usability failures are preventable — if you document the right way
6 FDA-aligned templates covering your entire HFE/UE process: plan, URRA, formative study, summative validation, use error analysis, and HFE summary report.
Comprehensive Human Factors Engineering plan aligned with FDA 2016 HFE guidance. Covers intended user population, use environments, device interfaces, known use problems, and the full summative validation plan. Required for all Class II/III 510(k) and PMA submissions.
Structured use-related risk analysis for identifying hazardous use scenarios. Maps each task to potential use errors, harm severity, and risk controls. Directly feeds your summative validation test scenarios.
Formative usability study protocol for early-stage iterative testing. Covers study objectives, participant criteria, task scenarios, moderator guide, observation forms, and deficiency log.
Summative HFE validation protocol meeting FDA 2016 HFE guidance requirements. Includes participant selection rationale, critical tasks identification, pass/fail criteria, simulated use procedures, and statistical sampling plan.
Structured template for analyzing use errors observed during summative testing. Covers error classification, root cause analysis, design mitigation assessment, and risk acceptability determination.
Complete HFE summary report for 510(k) and PMA submissions. Structured per FDA HFE guidance Section 9, covering device description, user interface summary, known use problems, summative study results, and conclusions on safe and effective use.
“We had three 510(k) submissions kicked back for HFE gaps. This framework finally got us through on the first try.”
“The summative protocol template alone is worth 10x the price. FDA reviewers specifically praised our HFE documentation.”
FDA expects summative HFE validation for all moderate-to-high risk devices where use error could cause serious harm. This includes most Class II 510(k) submissions and all PMAs. FDA 2016 HFE guidance is the primary reference.
No. Formative studies are iterative and exploratory. Summative studies are definitive validation with pre-specified pass/fail criteria. This toolkit includes separate templates for each.
The primary alignment is FDA 2016 HFE guidance. The URRA and summative protocol structures are compatible with IEC 62366-1 concepts but optimized for FDA 510(k) and PMA submissions.
Instant access · Editable Word/Markdown templates · FDA 2016 HFE guidance aligned